11 Jun 2021 Registration of Avacta’s AffiDX® SARS-CoV-2 Antigen Lateral Flow Test in EU Diagnostics | Investors
07 Jun 2021 MHRA Confirms Registration of Avacta’s AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Diagnostics | Investors
01 Jun 2021 Update on SARS-CoV-2 Antigen Lateral Flow Test Regulatory Submissions Diagnostics | Investors
23 Apr 2021 Preliminary Results for the year ending 31 December 2020 – Webinar presentation Investors
20 Apr 2021 Clinical validation of AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Diagnostics | Investors